NIH Weekly Funding Opportunities and Policy Notices
Notice NOT-CA-18-033 from the NIH Guide for Grants and Contracts
Notice NOT-NR-18-004 from the NIH Guide for Grants and Contracts
Notice NOT-NS-18-016 from the NIH Guide for Grants and Contracts
Notice NOT-CA-18-055 from the NIH Guide for Grants and Contracts
Notice NOT-HL-18-606 from the NIH Guide for Grants and Contracts
Funding Opportunity RFA-AI-18-005 from the NIH Guide for Grants and Contracts. The purpose of this funding opportunity announcement (FOA) is to solicit applications for the Sexually Transmitted Infections Cooperative Research Centers (STI CRC) program. This STI CRC program will facilitate multidisciplinary, synergistic collaborations to support the development of vaccines to control and prevent sexually transmitted infections (STIs) caused by the following pathogens, which have limited candidates in the product development pipeline: Neisseria gonorrhoeae, Chlamydia trachomatis, and Treponema pallidum. In addition, the FOA will support the development of prophylactic vaccines for herpes simplex virus (HSV).
Notice NOT-HL-18-607 from the NIH Guide for Grants and Contracts
Notice NOT-PM-18-002 from the NIH Guide for Grants and Contracts
Administrative Supplements for Research on Sexual and Gender Minority (SGM) Populations (Admin Supp)
Funding Opportunity PA-18-713 from the NIH Guide for Grants and Contracts. The National Institutes of Health (NIH) Office of the Director announces the availability of administrative supplements to expand existing research to focus on Sexual and Gender Minority (SGM) health. Principal Investigators holding specific types of NIH research grants, listed in the full Funding Opportunity Announcement (FOA) are notified that funds may be available for administrative supplements to meet increased costs that are within the scope of the approved award, but that were unforeseen when the new or renewal application or grant progress report for non-competing continuation support was submitted. Applications for administrative supplements are considered prior approval requests (as described in Section 8.1.2.11 of the NIH Grants Policy Statement) and will be routed directly to the Grants Management Officer of the parent award. Although requests for administrative supplements may be submitted through this FOA, there is no guarantee that funds are available from the awarding IC or for any specific grant. All applicants are encouraged to discuss potential requests with the awarding IC. Additionally, prior to submission, applicants must review the awarding IC's web site to ensure they meet the IC's requirements. SGM populations include, but are not limited to, lesbian, gay, bisexual, and transgender people, and individuals with differences or disorders of sexual development (sometimes referred to as intersex or as specific diagnoses). This trans-NIH effort, which involves multiple Institutes, Centers and Offices from across NIH, is intended to encourage investigation in this growing, field of research. To increase our collective understanding of the broad range of research needed to address the unique health issues of SGM populations, the supplement will focus on areas of research interest, including, but not limited to: studies on increased disease risk; mental, behavioral and social health; approaches to personalized medicine; access to care; reprod
Notice NOT-NS-18-050 from the NIH Guide for Grants and Contracts
Funding Opportunity RFA-FD-18-015 from the NIH Guide for Grants and Contracts. The FDA Center for Drug Evaluation and Research is encouraging applications for projects to expedite development of data standards and terminologies to support human drug development and evaluation. The primary objective is to support research and the development of non-proprietary, consensus-based, national data standards for use in clinical studies of human drugs and biologics. Projects may focus on solutions to general data standards development and implementation challenges or on specific clinical concepts, domains, or therapeutic areas where standardization is needed.
Funding Opportunity PAR-18-712 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to advance the discovery and characterization of primary immunodeficiency diseases, to understand the causes and mechanisms of disease, to enable early detection and molecular diagnosis, and to support the development of strategies to treat and eventually cure these disorders.
Funding Opportunity RFA-HL-19-016 from the NIH Guide for Grants and Contracts. This FOA encourages new R43 applications for design and development of technologies to monitor health or deliver care in a real-time, accessible, effective, and minimally obtrusive way for aging adults. These may be novel sensor or monitoring systems, home-use point-of-care devices, home or mobile therapy or rehabilitation tools, or information systems and should have the goal of fostering healthy and independent living. The development of such technologies should incorporate specific human factors for people with disabilities, people aging with mild impairments, as well as individuals with chronic conditions. Technology usability for these populations must be incorporated into the design early. Usability considerations include but are not limited to patient-facing displays, hearing and visual impairments considerations, tactile limitations, and literacy. These improvements in technology design could yield more accurate and earlier detection of changes that may interfere with healthy and independent living for older adults.
Notice NOT-GM-18-021 from the NIH Guide for Grants and Contracts
Notice NOT-DC-18-006 from the NIH Guide for Grants and Contracts
Funding Opportunity PAR-18-710 from the NIH Guide for Grants and Contracts. The objective of the NIH Career Transition Award (K22) is to provide support to outstanding basic or clinical investigators to develop their independent research skills through a two phase program: an initial period involving an intramural appointment at the NIH and a final period of support at an extramural institution. This NINDS K22 is specifically designed to facilitate the transition of NINDS intramural neurologist- and neurosurgeon-scientists to independent, academic faculty positions that support clinician-scientists to engage in independently funded scientific research as well as clinical activities.
Funding Opportunity PAR-18-711 from the NIH Guide for Grants and Contracts. The objective of the NIH Career Transition Award (K22) is to provide support to outstanding basic or clinical investigators to develop their independent research skills through a two phase program: an initial period involving an intramural appointment at the NIH and a final period of support at an extramural institution. This NINDS K22 is specifically designed to facilitate the transition of NINDS intramural neurologist- and neurosurgeon-scientists to independent, academic faculty positions that support clinician-scientists to engage in independently funded scientific research as well as clinical activities.
Notice NOT-AI-18-021 from the NIH Guide for Grants and Contracts
Notice NOT-OD-18-153 from the NIH Guide for Grants and Contracts
Funding Opportunity RFA-FD-18-008 from the NIH Guide for Grants and Contracts. FDA is announcing its intention to receive and consider a single source application for the award of a cooperative agreement in fiscal year 2018 to the University of California-Davis (UC Davis) to support the Western Center for Food Safety (WCFS). The purposes of this continued support are to: 1. Carry out multidisciplinary applied research that addresses "real world" issues related to food safety and food defense, agricultural practices, and the impact of agricultural practices on subsequent food processing associated with FDA-regulated products; 2. Develop and implement outreach and communication programs with stakeholders to identify research needs and to facilitate the utilization of the knowledge produced by the research program; 3. Provide opportunities to leverage additional resources among U.S. government agencies, non-governmental organizations, universities, industry, and consumers to achieve real-world solutions that address food safety and food defense issues. 4. Support the implementation of the Food Safety Modernization Act (FSMA) through research, education, and outreach with particular emphasis on the science behind the standards associated with the produce safety and preventive controls regulation.